This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Sanofi US Announces Winner Of 2013 Data Design Diabetes Innovation Challenge -- Prove It!

BRIDGEWATER, N.J., June 4, 2013 /PRNewswire/ -- Sanofi US announced today that Connect & Coach™ has been selected as the winning solution of the 2013 Data Design Diabetes (DDD) Innovation Challenge – Prove It! at Health Datapalooza IV in Washington, DC. Sanofi US will award Connect & Coach™ $100,000 to further develop its novel, data-driven solution to help improve health outcomes for people living with diabetes. Designed for the retail supermarket or pharmacy setting, Connect & Coach™ is the first hybrid clinical and consumer application for Registered Dietitians and Certified Diabetes Educators to help educate the diabetes community.

(Logo: http://photos.prnewswire.com/prnh/20130604/NY25770LOGO )

As part of this year's challenge, Sanofi US partnered with the Health Data Consortium to kick off the Redesigning Data Challenge Series. The Consortium, a collaboration among government, non-profit, and private sector organizations, works to foster innovative uses of data to improve health and healthcare. Through this unique partnership, DDD encourages participants to utilize or produce data that will fuel the tools to improve diabetes care in the U.S.

During the final stages of DDD, which is now in its third year, the five finalist teams participated in a Demo Day event at Health Datapalooza IV to showcase their noteworthy prototypes.  In addition to the winning solution Connect & Coach™, the other four finalist solutions included:

  • AllazoEngine: Leverages existing Allazo Health member data to both anticipate which patients will not take their medications and to predict the most effective interventions to influence each of those patients to take their medication.
  • GoCap: Replacement pen cap for prefilled insulin pens that can read dose amounts and times, and communicate wirelessly via Bluetooth to a mobile phone or connected glucometer.
  • MediSapien: Accepts isolated silos of unstructured health data and converts it into fully-coded structured data, empowering healthcare analytics for case management, pharmaceutical studies, trend analysis and academic research.
  • Nuduro: Provides home and on-the-go meal recommendations that match customers' taste and lifestyle with their unique nutritional needs.

"The Connect & Coach™ solution embodies the vision of Data Design Diabetes to find forward-thinking solutions that may help today's 26 million Americans who are living with diabetes," said Dennis Urbaniak, Vice President, U.S. Diabetes Patient Centered Unit, Sanofi US and DDD Judge.

Innovation challenges have become an integral part of the Sanofi US commitment to diabetes care.  As part of this commitment, Sanofi US also presented $5,000 to each of the 10 winners of Ignite: The Diabetes Ideas Challenge on May 30, 2013, which invited patients, caregivers, designers, engineers and innovators to submit ideas that could shape the design of a next-generation, insulin delivery device for people with diabetes. The winners of this year's Ignite Challenge are Being 'Sweet' Isn't Painful, Breeza: Insulin Inhaler Concept, Easy Insulin, EYECHECK, Insulin Printer, Kyrstalin, LEGO Insulin, MOVE, STAMP-IT, and stealth-IN. The concepts range from an insulin inhaler, to patch-based insulin delivery, to wearable insulin pumps, to an insulin printer that prepares needle-less insulin cartridges, and more.

For more information about the 2013 Data Design Diabetes Innovation Challenge – Prove It!, visit Twitter, Facebook, or the Data Design Diabetes blog. For more information about Ignite: The Diabetes Ideas Challenge, visit www.igniteideaschallenge.com.

About the Data Design Diabetes Innovation Challenge

Data Design Diabetes is a next-generation challenge offered by Sanofi US that brings together the richness of open datasets, the values of human-centered design, and the leading-edge methodology of the top innovation accelerators to find the next breakthrough to help millions of Americans living with diabetes.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,203.37 -85.26 -0.47%
S&P 500 2,107.78 -9.61 -0.45%
NASDAQ 4,979.9010 -28.1950 -0.56%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs